Furthermore, LITAF might facilitate cell apoptosis and terminal differentiation by transcriptional repression of BCL6, thereby increasing the likelihood of other genetic events associated with the development of B-cell lymphomas. Here, LITAF is linked to B-cell non-Hodgkin lymphoma.